2016 Early results of phase II trial of perioperative oxaliplatin and capecitabine (XELOX) without radiotherapy for high-risk rectal cancer (CORONA I). (September 2015) - Uehara, K.; Nakayama, G.; Ishigure, K.; Kobayashi, S.; Hiramatsu, H.; Nakayama, H.; Yamashita, K.; Sakamoto, E.; Tojima, Y.; Kawai, S.; Kodera, Y.; Nagino, M.